Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:978-983
Published online before print February 10, 2003, doi: 10.1161/01.CIR.0000051366.97361.EA
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/7/978    most recent
01.CIR.0000051366.97361.EAv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seferovic, P. M.
Right arrow Articles by Kanjuh, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seferovic, P. M.
Right arrow Articles by Kanjuh, V.
Related Collections
Right arrow Pericardial disease

(Circulation. 2003;107:978.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Diagnostic Value of Pericardial Biopsy

Improvement With Extensive Sampling Enabled by Pericardioscopy

Petar M. Seferovic, MD, PhD, FESC; Arsen D. Ristic, MD, FESC; Ruzica Maksimovic, MD, PhD; Vujadin Tatic, MD, PhD; Miodrag Ostojic, MD, PhD, FESC; Vladimir Kanjuh, MD, PhD

From the University Institute for Cardiovascular Diseases of the Medical Center of Serbia and Institute of Pathology and Forensic Medicine, Military Medical Academy (V.T.), Belgrade, Yugoslavia.

Correspondence to Petar M. Seferovic, MD, PhD, FACC, FESC, Professor and Head, Department of Cardiology 2, University Institute for Cardiovascular Diseases, Medical Center of Serbia, Koste Todorovica 8, 11000 Belgrade, Yugoslavia. E-mail eseferov{at}eunet.yu

Background— The clinical significance of pericardial biopsy is controversial. The aim of this study was to assess the feasibility and diagnostic value of 3 approaches to pericardial biopsy: fluoroscopic control and standard sampling, pericardioscopy guidance with standard sampling, and pericardioscopy guidance with extensive sampling.

Methods and Results— Forty-nine subsequent patients with a large pericardial effusion underwent parietal pericardial biopsy. In group 1 (12 patients, 66.7% males, age 46.7±12.2 years), pericardial biopsy was guided by fluoroscopy (3 to 6 samples per patient). Group 2 included 22 patients (50% males, age 50.8±10.4 years) undergoing 4 to 6 pericardial biopsies per patient guided by pericardioscopy (16F flexible endoscope). In group 3, extensive pericardial sampling was performed, guided by pericardioscopy (15 patients, 53.3% males, age 53.7±12.8 years, 18 to 20 samples per patient). Sampling efficiency was better with pericardioscopy (group 2, 84.9%; group 3, 84.2%) compared with fluoroscopic guidance (group 1, 43.7%; P<0.01). Diagnostic value was defined as a new diagnosis uncovered, etiology revealed, clinical diagnosis confirmed, and the biopsy false-negative. Pericardial biopsy in group 3 had higher diagnostic value than in group 1 in revealing new diagnosis (40% versus 8.3%, P<0.05) and etiology (53.3% versus 8.3%, P<0.05). In group 2, pericardial biopsy had a higher yield in establishing etiology than in group 1 (40.9% versus 8.3%; P<0.05). Pericardial biopsy was false-negative in 58.3% in group 1 in contrast to 6.7% in group 3 (P<0.01). There were no major complications.

Conclusions— Pericardioscopic guidance enhanced pericardial sampling efficiency. The diagnostic value of pericardial biopsy was significantly improved by extensive sampling made possible by pericardioscopy.


Key Words: biopsy • diagnosis • pericarditis • pericardium




This article has been cited by other articles:


Home page
Eur Heart JHome page
J. Soler-Soler, J. Sagrista-Sauleda, and G. Permanyer-Miralda
Aetiologic diagnosis of pericardial disease: worthy efforts may not be applied in the appropriate direction
Eur. Heart J., August 2, 2006; 27(16): 1898 - 1899.
[Full Text] [PDF]


Home page
CirculationHome page
W. C. Little and G. L. Freeman
Pericardial Disease
Circulation, March 28, 2006; 113(12): 1622 - 1632.
[Full Text] [PDF]


Home page
NEJMHome page
E. A. Nardell, D. Fan, J.-A. O. Shepard, and E. J. Mark
Case 22-2004 - A 30-Year-Old Woman with a Pericardial Effusion
N. Engl. J. Med., July 15, 2004; 351(3): 279 - 287.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al.
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
Eur. Heart J., April 1, 2004; 25(7): 587 - 610.
[Full Text] [PDF]


Home page
HeartHome page
G Permanyer-Miralda
Acute pericardial disease: approach to the aetiologic diagnosis
Heart, March 1, 2004; 90(3): 252 - 254.
[Full Text] [PDF]


Home page
HeartHome page
B. Maisch and A. D Ristic
Practical aspects of the management of pericardial disease
Heart, September 1, 2003; 89(9): 1096 - 1103.
[Full Text] [PDF]